Home
Redmile Group reported a 14.9% stake in Fate Therapeutics FATE · 18,229,078 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 14.9%
- Last report
- 14.9% · filed 25/07/03
- Shares held
- 18,229,078 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Redmile Group
- Event date
- 26/04/20
- Filed
- 26/04/22
14.9% stake · +0.0pp from the last report
- Stake
- 14.9%
- Last report
- 14.9%
- Since last report
- +0.0pp
Fate Therapeutics trades, last 26 weeks
What else happened in Fate Therapeutics around then
Filed or reported within 30 days of the trade day · 03/21~05/20Redmile Group's other 5% stake reports
- Redmile Group
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
8.7% stake
5,462,881 sh
8.7% stake
Filed 09/28
- Redmile Group
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
8.1% stake
8,782,256 sh
8.1% stake
Filed 08/14
- Redmile Group
5% stakeScholar Rock Holding
5% stakeScholar Rock Holding
SRRK
3.6% stake
4,311,092 sh
3.6% stake
Filed 08/14
- Redmile Group
5% stakeAtara Biotherapeutics
5% stakeAtara Biotherapeutics
ATRA
9.9% stake
950,994 sh
9.9% stake
Filed 07/24
- Redmile Group
5% stakeShattuck Labs
5% stakeShattuck Labs
STTK
9.9% stake
10,019,421 sh
9.9% stake
Filed 07/17
